Results 61 to 70 of about 18,157,587 (245)

Post-Coronavirus Disease 2019 Effects in an Active University Population: A Within-Campus Cross-Sectional Study at a Major Educational Institution

open access: yesMayo Clinic Proceedings: Innovations, Quality & Outcomes
Objective: To evaluate the associations among post-coronavirus disease 2019 (COVID-19) prevalence; risk factors and comorbidities have not been firmly established within a university outpatient population.
Marcelo Hernández-Mora, MD   +6 more
doaj   +1 more source

Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2

open access: yes, 2020
The outbreak of a novel coronavirus, which was later formally named the severe acute respiratory coronavirus 2 (SARS-CoV-2), has caused a worldwide public health crisis. Previous studies showed that SARS-CoV-2 is highly homologous to SARS-CoV and infects
Huanyu Tao   +4 more
core   +1 more source

Organizing the interface—Plasma membrane architecture and receptor dynamics in virus‐cell interactions

open access: yesFEBS Letters, EarlyView.
Plasma membranes contain dynamic nanoscale domains that organize lipids and receptors. Because viruses operate at similar scales, this architecture shapes early infection steps, including attachment, receptor engagement, and entry. Using influenza A virus and HIV‐1 as examples, we highlight how receptor nanoclusters, multivalent glycan interactions ...
Jan Schlegel, Christian Sieben
wiley   +1 more source

Susceptibility of lung cancer patients to COVID‐19: A review of the pandemic data from multiple nationalities

open access: yesThoracic Cancer, 2021
Several studies have highlighted that cancer patients tend to be more susceptible to develop severe infection and to die from COVID‐19. Certain medical conditions such as immunosuppression, presence of comorbidities, and underlying pulmonary damage are ...
Ana Emília Goulart Lemos   +3 more
doaj   +1 more source

Proyecto Argentino Interinstitucional de genómica de SARS-CoV-2. Reporte Nº 1 Inicial. “Análisis de secuencias de SARS-CoV-2 obtenidas de pacientes con COVID-19 de Argentina”

open access: yes, 2020
Hasta el 9 de septiembre 2021 el Proyecto a generado 26 Reportes. Reporte nro 1 - Análisis inicial. Reporte nro 2 – Patagonia. Reportes nro 3 y 4 - CABA y Prov. BsAs. Reporte nro 5 – Córdoba. Reporte nro 6 – Chaco. Reporte UK.
Consorcio Argentino de Genómica de SARS-CoV-2
core  

Biophysical approaches for studying viral entry

open access: yesFEBS Letters, EarlyView.
Viruses infect all living organisms and have been responsible for major epidemics and pandemics. Their ongoing evolutionary battle with host defenses creates a constant need for improved tools to study viral behavior. Advancing methods to probe viral attachment, fusion, and genome release deepen our understanding of how infections begin and support the
Inbar Yosibash, Raya Sorkin
wiley   +1 more source

Whole genome sequencing of recombinant viruses obtained from co-infection and superinfection of Vero cells with modified vaccinia virus ankara vectored influenza vaccine and a naturally occurring cowpox virus

open access: yesFrontiers in Immunology
Modified vaccinia virus Ankara (MVA) has been widely tested in clinical trials as recombinant vector vaccine against infectious diseases and cancers in humans and animals.
Diana Diaz-Cánova   +4 more
doaj   +1 more source

SARS-CoV-2

open access: yes, 2020
Structural model of SARS-CoV-2 including the X rays structure of the spikes (PDB ID 6VSB). The model is composed of cryoEM density from SARS-CoV-1 for the core and SARS-CoV-2 spikes pdbs.
Dr Victor Padilla-Sanchez, PhD (8627079)
core   +1 more source

Rapid screening of staphylokinase protein variants using an unpurified cell‐free expression system

open access: yesFEBS Open Bio, EarlyView.
An unpurified cell‐free protein synthesis (CFPS) platform enables rapid functional screening of staphylokinase variants. Direct plasminogen‐activation assays performed in microplate format provide real‐time activity readouts, allowing rapid identification and ranking of variants with improved or reduced fibrinolytic activity without protein ...
Maria Tomková   +3 more
wiley   +1 more source

Оценка Т-клеточного иммунитета к SARS-CoV-2 у переболевших и вакцинированных против COVID-19 лиц с помощью ELISPOT набора ТиграТест® SARS-CoV-2

open access: yes, 2021
With the onset of the COVID-19 pandemic, a number of molecular-based tests have been developed to diagnose SARS-CoV-2 infection. However, numerous available serological tests lack sufficient sensitivity or specificity.
Р. А. Хамитов   +11 more
core   +1 more source

Home - About - Disclaimer - Privacy